Therapeutic effect of selective serotonin reuptake inhibitors to gain-of-function KCND3 variant identified in a patient with early repolarization and refractory epilepsy.
1 September 2025 (11:15 - 12:00)
Organised by: 

About the speaker

National Cerebral & Cardiovascular Center, Suita (Japan)
7 More presentations in this session

Doctor A. Savelev (Lund, SE)
Access the full session
The Event
ESC Congress 2025
1 September 2025
11:15 CET
You may be interested in
Congress Presentation
Congress Presentation




